Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Manual for Tracking down the Immaculate Magnificence of Focal Asia - 2Blue Origin's next space tourism flight will break new ground for people with disabilities
- 3Holiday weather forecast: Where travelers can expect a wintry mix, flooding and record warmth across the U.S.
- 4Israeli archaeologists launch project to trace origins of ancient pottery
- 5Tech for Wellbeing: Applications and Devices for a Better You
- How to watch NASA's Artemis 2 astronauts launch to the moon on April 1
- Figure out how to Put resources into Lab Precious stones: A Novice's Aide
- 5 Advancement Developments in Biotechnology
- Savvy Tips for Seniors Hyundai IONIQ EV
- Dental Embed Innovation: An Achievement in Helpful Dentistry
- Dark matter obeys gravity after all — could that rule out a 5th fundamental force in the universe?
- West Antarctica’s history of rapid melting foretells sudden shifts in continent’s ‘catastrophic’ geology
- Dear Santa: I want Botox. Why cosmetic procedures are topping holiday wish lists.
- Brazil's Bolsonaro to continue his sentence at home because of poor health
